Lukanova, A., Becker, S., Hüsing, A., Schock, H., Fedirko, V., Trepo, E., Trichopoulou, A., Bamia, C., Lagiou, P., Benetou, V., Trichopoulos, D., Nöthlings, U., Tjønneland, A., Overvad, K., Dossus, L., Teucher, B., Boeing, H., Aleksandrova, K., Palli, D., Pala, V., Panico, S., Tumino, R., Ricceri, F., Bueno‐de‐Mesquita, H. B., Siersema, P. D., Peeters, P. H., Quiros, J. R., Duell, E. J., Molina‐Montes, E., Chirlaque, M., Gurrea, A. B., Dorronsoro, M., Lindkvist, B., Johansen, D., Werner, M., Sund, M., Khaw, K., Wareham, N., Key, T. J., Travis, R. C., Rinaldi, S., Romieu, I., Gunter, M. J., Riboli, E., Jenab, M., & Kaaks, R. (n.d.). prediagnostic plasma testosterone, sex hormone‐binding globulin, IGF‐I and hepatocellular carcinoma: Etiological factors or risk markers?. International journal of cancer, 134(1), 164–173. http://access.bl.uk/ark:/81055/vdc_100024576118.0x00004f